Business
Entrepreneurs assemble: The pandemic isn't stopping entrepreneurs — quite the opposite in fact

Entrepreneurs assemble: The pandemic isn't stopping entrepreneurs — quite the opposite in fact

The entrepreneurial spirit is alive and kicking. New businesses are being formed at a phenomenal rate ever since the pandemic gripped the US in the middle of last year. Data from the US Census Bureau reveals that there were more than 4.25 million new business applications last year, up more than 20% on the year before. The data for 2021 so far is even more impressive — with more business applications being filed so far than any year that's been tracked since 2006.

Never waste a crisis

Never let a good crisis go to waste were famous words supposedly said by Winston Churchill — and often echoed now by many entrepreneurs. With much of our economy in upheaval new sectors, products and services are cropping up at an astounding rate and if you are an entrepreneur starting a company during this recession, it's hard not to be inspired by some of the successes from the past. The last major global recession saw Uber, Airbnb, Slack and WhatsApp get started — to name but a few.

Why is now a "good" time?

It's a bit counter-intuitive for people to take more risks when the economy is in such dire straits, but there are a lot of reasons to support why we're seeing this:

  • New work paradigm. Offices and office space will change forever — and that means opportunities for physical and digital products (collaboration software, home office desks etc.).

  • Funding is available. We might be in a recession, but venture capital funding is still widely available, and was actually up 13% last year.

  • Time. Furloughed workers, or those with reduced hours, may now have the time to turn that side-hustle or side-project into a more substantial venture.

  • Necessity, the mother of all invention. Lost your job? You may not have much choice but to start your own company and try and go it alone.

More Business

See all Business
business

Ford reportedly in talks to buy hybrid vehicle batteries from Chinese auto giant BYD

Detroit’s Ford and China’s BYD are said to be in ongoing talks to partner on an agreement that would see Ford buy hybrid vehicle batteries from BYD, according to reporting from The Wall Street Journal.

The report comes just days after President Trump toured a Ford factory in Michigan and implied openness to Chinese automakers coming to the US.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

Still life of Ozempic and Wegovy with weight scale.

Lawsuit alleges Lilly, Novo locked up telehealth to kill compounded GLP-1s

Novo Nordisk CEO Mike Doustdar estimated that around 1.5 million US patients are using compounded versions of the company’s drugs.

Handshake

Big Pharma enters 2026 with an appetite for deals

At the JPMorgan Healthcare Conference, biotechs and Big Pharma signaled they’re primed for M&A this year, after a big year for deals in 2025.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.